Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Friday, November 22, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Friday, November 22, 2024 | Latest Paper
Subscribe Now

TRENDING:

Sharon Batt

Sharon Batt

Pharmacare, patient groups, and the need for open discourse

  • Will Canadians ever have the universal national pharmacare program that repeated investigations show will support fair, appropriate health care and that 86 per cent
Opinion | BY SHARON BATT | February 8, 2021
Canada's federal Health Minister Patty Hajdu, pictured Dec. 11, 2020, is tasked with taking steps towards a national pharmacare program. Professor Sharon Batt writes that with industry-funded patient groups advocating against it, will it ever become a reality? The Hill Times photograph by Andrew Meade

Pharmacare, patient groups, and the need for open discourse

Opinion | BY SHARON BATT | February 8, 2021
  • Will Canadians ever have the universal national pharmacare program that repeated investigations show will support fair, appropriate health care and that 86 per cent

Pharmacare, patient groups, and the need for open discourse

Opinion | BY SHARON BATT | February 8, 2021
  • Will Canadians ever have the universal national pharmacare program that repeated investigations show will support fair, appropriate health care and that 86 per cent
Canada's federal Health Minister Patty Hajdu, pictured Dec. 11, 2020, is tasked with taking steps towards a national pharmacare program. Professor Sharon Batt writes that with industry-funded patient groups advocating against it, will it ever become a reality? The Hill Times photograph by Andrew Meade

Pharmacare, patient groups, and the need for open discourse

  • Will Canadians ever have the universal national pharmacare program that repeated investigations show will support fair, appropriate health care and that 86 per cent
Opinion | BY SHARON BATT | February 8, 2021
Canada's federal Health Minister Patty Hajdu, pictured Dec. 11, 2020, is tasked with taking steps towards a national pharmacare program. Professor Sharon Batt writes that with industry-funded patient groups advocating against it, will it ever become a reality? The Hill Times photograph by Andrew Meade

Pharmacare, patient groups, and the need for open discourse

Opinion | BY SHARON BATT | February 8, 2021
  • Will Canadians ever have the universal national pharmacare program that repeated investigations show will support fair, appropriate health care and that 86 per cent

Pharmacare, patient groups, and the need for open discourse

Opinion | BY SHARON BATT | February 8, 2021
  • Will Canadians ever have the universal national pharmacare program that repeated investigations show will support fair, appropriate health care and that 86 per cent
Canada's federal Health Minister Patty Hajdu, pictured Dec. 11, 2020, is tasked with taking steps towards a national pharmacare program. Professor Sharon Batt writes that with industry-funded patient groups advocating against it, will it ever become a reality? The Hill Times photograph by Andrew Meade

Will the government seek independent patient input on drug policy?

  • HALIFAX—In the lead-up to some form of national pharmacare, the Trudeau government plans to launch a new national Canadian Drug Agency as policy central
Opinion | BY SHARON BATT | February 3, 2020
Prime Minister Justin Trudeau, pictured on Nov. 14, 2019, meeting with New Democratic Party Leader Jagmeet Singh in the prime minister's West Block office. Sharon Batt writes that she is cautiously hopefuly the government 'will jettison a longstanding, dubious practice: soliciting input from patient advocacy groups funded by the pharmaceutical industry.'  The Hill Times photograph by Andrew Meade

Will the government seek independent patient input on drug policy?

Opinion | BY SHARON BATT | February 3, 2020
  • HALIFAX—In the lead-up to some form of national pharmacare, the Trudeau government plans to launch a new national Canadian Drug Agency as policy central

Will the government seek independent patient input on drug policy?

Opinion | BY SHARON BATT | February 3, 2020
  • HALIFAX—In the lead-up to some form of national pharmacare, the Trudeau government plans to launch a new national Canadian Drug Agency as policy central
Prime Minister Justin Trudeau, pictured on Nov. 14, 2019, meeting with New Democratic Party Leader Jagmeet Singh in the prime minister's West Block office. Sharon Batt writes that she is cautiously hopefuly the government 'will jettison a longstanding, dubious practice: soliciting input from patient advocacy groups funded by the pharmaceutical industry.'  The Hill Times photograph by Andrew Meade
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu